Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
MICROZIDE
Generic name / active ingredient
hydrochlorothiazide
Dosage-form class
Hydrochlorothiazide 12.5 mg oral capsule; not a hydrochlorothiazide tablet or a combination tablet that already contains hydrochlorothiazide
Route
Oral
Record reviewed
2026-08-29

Copy from the pack in hand

Source-linked reading points

  • Read the active ingredients on every pack. AVALIDE already contains irbesartan/hydrochlorothiazide, while EXFORGE HCT contains amlodipine/valsartan/hydrochlorothiazide. If MICROZIDE or another HCTZ product is also on the full list, ask a pharmacist or prescriber to check for duplication; do not stop one yourself.
  • Dry mouth, marked thirst, weakness, drowsiness, restlessness, muscle pain or cramps, fast heartbeat, dizziness, clearly reduced urine, persistent nausea or vomiting may accompany fluid or electrolyte changes. Seek local emergency help for severe or sudden symptoms, fainting or altered consciousness.
  • Older adults, kidney or liver impairment, gout or high urate, diabetes, and co-use of other blood-pressure medicines, digoxin, corticosteroids, lithium, pain or anti-inflammatory medicines, or alcohol all require review of the exact packs and complete medicine list. The site does not generate an adjustment from age, laboratory or blood-pressure numbers.
  • Sudden eye pain, rapid loss of vision or marked blurred vision needs prompt medical assessment. Swelling of the face, lips, tongue or throat, breathing difficulty or a severe skin reaction requires local emergency services. Do not wait for the website to decide whether the medicine caused it.

Reviewed presentation examples — compare every field

  • Hydrochlorothiazide 12.5 mg per capsule; 100-capsule bottle (historical pack)NDC 52544-622-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-29
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image